Drug Discovery

Screening the invisible

Cisbio Bioassays, now a member of the IBA group, is a life sciences company committed to improving human healthcare with more than 30 years of experience in the fields of medical diagnostics and drug discovery. The company supplies best-in-class products and services that are designed and developed for researchers in the pharma and biotech industries and in academic research who shape the drugs of tomorrow.

Cisbio Bioassays has made life sciences innovation its pivotal mission in order to meet the ever evolving needs of the scientific community.  Its tools and technologies are used for the investigation and screening of main therapeutic target classes including cell surface receptors, kinases and other key elements of cell function, research which is crucial to the discovery of new therapeutics.

 
 
 
  • Cisbio Bioassays' innovation
  • Cisbio Bioassays' expertise in immunoassay design, combined with the findings of Prof. Jean-Marie Lehn in the chemistry of fluorescence rare earth complexes (Nobel prize in Chemistry, 1987) led to the development of HTRF®, its pioneering technology that is recognized as a reference in life sciences.
  • cAMP, IP-One and Cellul'erk assays, and now the Tag-lite technological platform, are used by most pharma and biotech companies for the study of G-protein coupled receptors, one of the most important target classes in drug discovery
  • HTRF® has also been applied for over 10 years to kinase screening, a category of enzymes that is key to oncology research
  • Cisbio Bioassays’ team of scientists and engineers are recognized for their expertise in assay development technologies and sought after by pharma, biotech, and research partners.
 

 

You are here : Home › IBA Solutions › Drug Discovery
We Protect, Enhance, and Save lives © IBA 2009 | All rights reserved | Site map | made by Globule Bleu